Clinical Trials Logo

Filter by:
NCT ID: NCT06286696 Not yet recruiting - Hypertension Clinical Trials

Optic Nerve Sheath Diameter in Hypertensive Emergency

OpticUS
Start date: April 1, 2024
Phase:
Study type: Observational

This prospective observational study investigates the potential of point-of-care ultrasonography of the optic nerve sheath diameter (ONSD) to rule out papilledema in patients with suspected hypertensive emergency. The primary focus is on assessing ONSD sensitivity in identifying papilledema (hypertensive retinopathy grade 4), while secondary endpoints include hypertensive retinopathy grade 3, hypertensive encephalopathy, and the need for intravenous rapid-acting medications to lower elevated blood pressure. This study aims to determine the diagnostic characteristics of this procedure for the diagnosis of hypertensive retinopathy, thus assessing its potential as a screening tool to rule out hypertensive retinopathy by the acute internal medicine doctor.

NCT ID: NCT06286904 Not yet recruiting - Pregnant Women Clinical Trials

Sleep Position Pattern Recording

Start date: April 1, 2024
Phase:
Study type: Observational

The main goal of this study is to validate the accuracy of the body position detection by non-invasive wearable monitors (Skiin garments, Myant Medical Corp) during sleep in pregnant participants. This is a first step towards examining the association between maternal sleep position and fetal growth.

NCT ID: NCT06288022 Not yet recruiting - Safety Issues Clinical Trials

Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

Limited literature has focused on the use of totally tubeless mini-percutaneous nephrolithotomy (Mini-PCNL) for the treatment of large renal stones. This Randomized Controlled trial aims to compare complication and safety of Mini-PCNL between total tubeless and tubeless Mini-PCNL.

NCT ID: NCT06288568 Not yet recruiting - Obesity Clinical Trials

Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers

Shift2Health
Start date: April 1, 2024
Phase:
Study type: Observational

Shift work is a well-known risk factor for the development of overweight and obesity, which may lead to downstream effects such as increased risk of cardiometabolic diseases and cancer. However, the biological and behavioral mechanisms underlying the obesogenicity of night shift work are not well understood. Population-based mechanistic studies in real life shift workers are needed to address how night shift work impacts metabolic health. The investigators aim to characterize the behavioural, environmental, and biological mechanisms and pathways for the association of night shift work and obesity across Europe. The investigators will conduct a cross sectional study in 5 European countries (Austria, Denmark, Germany, Netherlands and Poland) and recruit 1000 rotating night shift workers and day workers (200/country) from the health sector and different industries. Night and day workers will be age-frequency (3 age groups), gender and (where possible) working tasks matched. Participants will complete online questionnaires and report their diet habits in a mobile app. Body composition, dietary behavior and sensory preferences will be tested. Biologic specimens (blood, urine, saliva, hair and feces) will be collected at the workplace on a day where participants are working on a day shift (or a day off). In a subsample (Austria and Netherlands) shift workers will provide biological samples (spot blood, urine and saliva) both on a day shift and on a night shift. Biomarkers including hormones, cellular immunity and inflammation, parameters linked to gut health and metabolism of fat and sugar, appetite, oxidative stress, metabolomics and microbiota will be measured. The investigators hypothesize that compared to day workers, night shift workers will experience disrupted levels of pre-obesity markers. Higher circadian disruption, sleep disruption and mistimed eating patterns workers will be associated with more disrupted biomarker profiles. Among rotating shift workers, night shift will be associated with acute disrupted melatonin production, metabolomic profiles and composition of oral microbiota compared to a day shift.

NCT ID: NCT06288867 Not yet recruiting - Hip Injuries Clinical Trials

A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study aims to address hip labral tears and compare between arthroscopic labral repair versus debridement.

NCT ID: NCT06288893 Not yet recruiting - COVID-19 Clinical Trials

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Start date: April 1, 2024
Phase: Phase 2
Study type: Interventional

Randomized, double-blind, placebo-controlled, multicenter phase II clinical study of SHEN211 tablets

NCT ID: NCT06289361 Not yet recruiting - HIV Infections Clinical Trials

Cohort IMEA 070 -Lenacapavir Compassional

Start date: April 1, 2024
Phase:
Study type: Observational

Immunovirological follow-up and safety of HIV-infected patients receiving lenacapavir under compassionate access in France between 01/01/2021 and 12/31/2023

NCT ID: NCT06289517 Not yet recruiting - Neoplasms Clinical Trials

PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 Expression

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This project uses HER2 protein as the target group of radiodrugs to explore the diagnostic efficacy, safety and metabolic characteristics of 68Ga-Her2-affibody in the expression status of HER2, aiming to provide a new imaging method for the determination of HER2 status in breast cancer At the same time, it also provides new methods and means for early diagnosis, accurate staging, recurrence judgment, treatment decision-making and prognosis judgment of malignant tumors such as lung cancer, gastrointestinal cancer and bladder cancer, and provides scientific basis for precise treatment of malignant tumors.

NCT ID: NCT06289855 Not yet recruiting - Parkinson's Disease Clinical Trials

Impulse Control Disorder Among Parkinson's Disease Patients

Start date: April 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about impulse control disorders in Parkinson's disease patients. The main question: it aims to answer: - Detect Relative frequency of impulse control disorder among Parkinson's disease patients - Detect Relation between impulse control disorders, and other non motor and motor symptoms in Parkinson's disease patients, using clinical, neurophysiological and radiological assessment

NCT ID: NCT06290115 Not yet recruiting - Adolescents Clinical Trials

Adolescents' Non-suicidal Behavior and Perception of Parents' Negative Emotional Expression and Family Communication

Start date: April 1, 2024
Phase:
Study type: Observational

The starting point of this project is to study young people and adolescents, aiming to explore the correlation between non-suicidal behavior of young people and adolescents and the negative emotional expression of their parents and family communication. The purpose of this project is to investigate the non-suicidal self-injury behavior of teenagers aged 15-25 years by issuing questionnaires (sample size: 327 people). In order to find out whether there is any connection between family communication and non-suicidal self-injury behavior of young people and adolescents.